DOSSIER · 13F Holders · Q2 2026
4D MOLECULAR THERAPEUTICS IN
3 institutions still hold 4D MOLECULAR THERAPEUTICS IN as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 35104E950·3 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
3 institutions reported 4D MOLECULAR THERAPEUTICS IN in Q2 2026. GROUP ONE TRADING LLC leads at 52.6% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.